000 01788nam  2200385zi 4500
0019.875270
003CaOODSP
00520221107164419
006m     o  d f      
007cr |||||||||||
008190621e201906##onc    #ob   f000 0 eng d
040 |aCaOODSP|beng|erda|cCaOODSP
043 |an-cn---
0861 |aXC78-1/1-421-14E-PDF
1101 |aCanada. |bParliament. |bHouse of Commons. |bStanding Committee on Veterans Affairs.
24510|aEffects of mefloquine use among Canadian veterans / |cNeil R. Ellis, chair.
264 1|a[Ottawa] : |bHouse of Commons = Chambre des communes, |cJune 2019.
300 |a1 online resource (vii, 34 pages).
336 |atext|btxt|2rdacontent
337 |acomputer|bc|2rdamedia
338 |aonline resource|bcr|2rdacarrier
4901 |aReport of the Standing Committee on Veterans Affairs ; |v14th report, 42nd Parliament, 1st session
500 |aIssued also in HTML format.
500 |aOriginal published on: 2019/06/19; published on: 2019/08/22.
500 |aIssued also in French under title: Les conséquences de l’usage de la méfloquine chez les vétérans canadiens.
504 |aIncludes bibliographical references.
69207|2gccst|aVeterans
69207|2gccst|aMedicine
69207|2gccst|aHealth
7001 |aEllis, Neil R.
77508|tLes conséquences de l’usage de la méfloquine chez les vétérans canadiens / |w(CaOODSP)9.875274
830#0|aReport of the Standing Committee on Veterans Affairs ;|v14th report, 42nd Parliament, 1st session.|w(CaOODSP)9.506809
85640|qPDF|s3.01 MB|uhttps://publications.gc.ca/collections/collection_2019/parl/xc78-1/XC78-1-1-421-14-eng.pdf
8564 |qHTML|sN/A|uhttps://www.ourcommons.ca/DocumentViewer/en/42-1/ACVA/report-14